The Genomic Era 2.0: Strategic Value Creation in a Data-Driven Bio-Economy
The Genomics Market has moved beyond the era of foundational sequencing into an era of functional application. In 2025, the industry is no longer just reading the genetic code; it is interpreting and editing it at an industrial scale. For B2B stakeholders—from biopharmaceutical firms to clinical research organizations—the market represents a high-velocity ecosystem where Next-Generation … Read more